News: Moderna聲稱針對奧密的雙價新冠疫苗效果好，將申請FDA許可

Moderna says updated Covid-19 vaccine booster shows stronger antibody response against Omicron
 

https://www.cnn.com/2022/06/08/health/moderna-omicron-booster-results/index.html

Bivalent boosters address two viral strains in the same vaccine. The updated booster contains Moderna's original vaccine, and a vaccine candidate that targets the Omicron variant.

The vaccine was generally well-tolerated, the company said, with side effects similar to booster doses of the current vaccine. 

The 50-microgram bivalent booster, called mRNA-1273.214, generated a stronger antibody response against Omicron than the original Moderna vaccine. Omicron subvariants are driving virtually all the new Covid-19 cases in the United States right now.
 

 

 

Moderna seeking FDA authorization of omicron-specific booster shot
 

https://www.washingtonpost.com/health/2022/06/08/moderna-booster-omicron-coronavirus-trial/

Moderna said it will seek authorization for an updated coronavirus vaccine designed to protect against omicron subvariants that the company described as its “lead candidate” for a fall booster, but it remains unclear how effective the shot will be against the latest versions of the omicron variant spreading in the United States.